Kahn Clare
SEC insider (Form 3/4/5 filer). CIK 0001849236. Director at Solid Biosciences Inc. (SLDB) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in CHARLESTOWN, MA.
Companies Kahn Clare has filed insider reports for
- Solid Biosciences Inc. (SLDB): Director
- Stoke Therapeutics, Inc. (STOK): Director
Kahn Clare
CIK: 0001849236
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 10, 2026SLDB
Solid Biosciences Inc.
AwardDirectDirector Stock Option (Right to Buy)
77.5K shares- - Apr 3, 2026STOK
Stoke Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
30.8K shares- - Jun 12, 2025SLDB
Solid Biosciences Inc.
AwardDirectDirector Stock Option (Right to Buy)
77.5K shares- - Mar 11, 2025SLDB
Solid Biosciences Inc.
PurchaseDirect1.9K shares at avg. $5.34$10K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  SLDB Solid Biosciences Inc. | Award Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| Apr 3, 2026 |  STOK Stoke Therapeutics, Inc. | Award Stock Option (Right to Buy) | 30,782 | - | - | Direct |
| Jun 12, 2025 | SLDB Solid Biosciences Inc. | Award Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| Mar 11, 2025 | SLDB Solid Biosciences Inc. | Purchase | 1,860 | $5.34 | $9,924 | Direct |
1-4 of 4 transactions